The Columbia University Department of Systems Biology brings together researchers specializing in computational biology, experimental biology, and technology development to discover how biological traits emerge from complex molecular networks.
Systems biology and computational biology are becoming increasingly important disciplines in the biological sciences. Through PhD graduate education and postdoctoral training we prepare young scientists to become leaders in this exciting and rapidly growing field.
Raul Rabadan Wins Stand Up to Cancer Award for Accelerated Cancer Research
Dr. Rabadan has won a Sharp Innovation Award from Stand Up to Cancer, and with collaborator, Dr. Dan Landau of Weill Cornell, the two investigators will work on a novel sequencing technique and computational method for better understanding immune recognition mechanism in glioblastoma.
Building a Better Way to Decode the Genome
Columbia University researchers have developed a computational tool that shines a light on the genome’s most hard-to-translate segments. With this tool in hand, scientists can get closer to understanding how DNA guides everything from growth and development to aging and disease.
Gaining Momentum on the Human Cell Atlas
Systems Biology Department Chair Andrea Califano has received a new grant from the Chan Zuckerberg Initiative to fund innovative research contributing to the Human Cell Atlas. This global endeavor aims to define every cell type of the human body, with the idea of creating a collection of maps for the cellular basis of health and disease.
Two Faculty Win Vagelos Precision Medicine Pilot Award
Professors Harmen Bussemaker and Tuuli Lappalainen have received an inaugural Roy and Diana Vagelos Precision Medicine Pilot Award. Their research collaboration will bridge quantitative genetics and mechanistic biology to better understand regulatory effects of genetic variants in humans.
Organoids Created from Patients’ Bladder Cancers Could Guide Treatment
A study, led by Professor Michael Shen, published in Cell, details the development of patient-specific bladder cancer organioids that mimic many of the characteristics of actual tumors. The use of organoids may be useful in the future to guide treatment of patients.
Events and Seminars
April 27, 2018 - 3:00pm
Benjamin Greenbaum, PhD(Icahn School of Medicine at Mount Sinai)
May 2, 2018 - 3:00pm
Brian Shoichet(University of California-San Francisco)